Journey Medical Corporation has announced the launch and initial distribution of Emrosi™, a new prescription medication designed to treat inflammatory lesions of rosacea in adults. Emrosi, which ...

For many women, midlife brings a new sense of self-assurance, but it can also bring unexpected changes in skin health. One of the most frustrating and often misunderstood conditions that tends to ...

Do you feel like you’re always blushing or breaking out in pimples? You may have rosacea, a skin condition that affects more than 16 million Americans. Fortunately, doctors have tools to help. Other ...

It's still early science -- studies in mice and in human cells -- but researchers are on the trail of an effective new treatment for inflammatory skin conditions such as rosacea. Skin cells called ...

In skincare, few conditions are as stubborn and frustrating as rosacea and persistent redness. These skin issues affect one’s appearance and can lead to a lack of confidence and social discomfort. As ...

Please provide your email address to receive an email when new articles are posted on . IGA success rates and lesion count reductions were higher in those treated with Emrosi vs. placebo or Oracea.

Over 5% of adults are thought to have the chronic skin condition, but far fewer than that ever seek treatment for it. Reading time 5 minutes A rosy, flushed face can be a sign of embarrassment, ...

CINCINNATI (WKRC ) - A new combination therapy is showing promise in reducing facial redness caused by rosacea, a common skin condition. Dr. Elizabeth Muennich of Dermatology and Skin Care Associates ...

Fortress Biotech announces Emrosi™ launch for rosacea, Checkpoint's acquisition by Sun Pharma, and CUTX-101 NDA acceptance for Menkes disease. Fortress Biotech, Inc. has announced a commercial launch ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Rosacea is a chronic skin condition that causes redness, irritation, and sometimes painful flare-ups.

Lower dietary antioxidant intake is linked to higher oxidative stress in rosacea, with potential implications for disease ...

Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug Administration approved its Emrosi drug for the treatment of rosacea. What Happened: ...